These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8676811)

  • 1. Lipoprotein(a) in chronic renal disease.
    Stenvinkel P; Berglund L
    Miner Electrolyte Metab; 1996; 22(1-3):16-21. PubMed ID: 8676811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein(a) serum levels and apolipoprotein(a) phenotypes in children with chronic renal disease.
    Querfeld U; Lang M; Friedrich JB; Kohl B; Fiehn W; Schärer K
    Pediatr Res; 1993 Dec; 34(6):772-6. PubMed ID: 8108191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein(a) in nephrotic syndrome and end-stage renal disease.
    Greiber S; Wanner C
    Miner Electrolyte Metab; 1997; 23(3-6):161-5. PubMed ID: 9387108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with renal failure.
    Milionis HJ; Elisaf MS; Tselepis A; Bairaktari E; Karabina SA; Siamopoulos KC
    Am J Kidney Dis; 1999 Jun; 33(6):1100-6. PubMed ID: 10352198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a).
    Dieplinger H; Lackner C; Kronenberg F; Sandholzer C; Lhotta K; Hoppichler F; Graf H; König P
    J Clin Invest; 1993 Feb; 91(2):397-401. PubMed ID: 8432847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Alterations of Lp (a) lipoprotein in patients with chronic renal failure treated by continuous ambulatory peritoneal dialysis].
    Takegoshi T; Kitoh C; Shimada T; Kawai K; Yamazaki Y; Mabuchi H
    Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):757-63. PubMed ID: 8377289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High lipoprotein(a) levels and small apolipoprotein(a) size prospectively predict cardiovascular events in dialysis patients.
    Longenecker JC; Klag MJ; Marcovina SM; Liu YM; Jaar BG; Powe NR; Fink NE; Levey AS; Coresh J
    J Am Soc Nephrol; 2005 Jun; 16(6):1794-802. PubMed ID: 15800123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetics and metabolism of lipoprotein(a) and their clinical implications (Part 1).
    Dieplinger H; Kronenberg F
    Wien Klin Wochenschr; 1999 Jan; 111(1):5-20. PubMed ID: 10067265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is an elevated level of serum lipoprotein (a) a risk factor for cardiovascular disease in CAPD patients?
    Avram MM; Sreedhara R; Patel N; Chattopadhyay J; Thu T; Fein P
    Adv Perit Dial; 1996; 12():266-71. PubMed ID: 8865917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lipoprotein (a) in children with end stage renal failure on maintenance hemodialysis and continuous ambulatory peritoneal dialysis].
    Zwolińska D; Szprynger K
    Przegl Lek; 1997; 54(5):320-3. PubMed ID: 9380806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A study of clinical significance of Lp[a] lipoprotein in patients with chronic renal failure treated by hemodialysis].
    Takegoshi T; Kitoh C; Yamazaki Y
    Nihon Jinzo Gakkai Shi; 1990 Jun; 32(6):667-71. PubMed ID: 2145455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum lipoprotein (a) in renal transplant recipients receiving cyclosporin monotherapy.
    Brown JH; Anwar N; Short CD; Bhatnager D; Mackness MI; Hunt LP; Durrington PN
    Nephrol Dial Transplant; 1993; 8(9):863-7. PubMed ID: 8255521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Plasma nicotinic acid levels in hemodialysis patients after the administration of niceritrol].
    Saika Y; Kodama N; Kimura K; Fujii R; Ohtani H; Mune M; Mimura K; Maeda T; Yukawa S
    Nihon Jinzo Gakkai Shi; 1999 Jun; 41(4):430-5. PubMed ID: 10441992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperhomocysteinemia and protein damage in chronic renal failure and kidney transplant pediatric patients--Italian initiative on uremic hyperhomocysteinemia (IIUH).
    Perna AF; Ingrosso D; Molino D; Galletti P; Montini G; Zacchello G; Bellantuono R; Caringella A; Fede C; Chimenz R; De Santo NG
    J Nephrol; 2003; 16(4):516-21. PubMed ID: 14696753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lipoprotein (a) in children with chronic renal failure treated conservatively].
    Zwolińska D; Kiliś-Pstrusińska K; Szprynger K
    Pol Merkur Lekarski; 1997 Sep; 3(15):126-8. PubMed ID: 9461709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxalic Acid as a uremic toxin.
    Mydlík M; Derzsiová K
    J Ren Nutr; 2008 Jan; 18(1):33-9. PubMed ID: 18089441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of change of renal replacement therapy on serum lipoprotein (a) concentration.
    Misra M; Webb AT; Reaveley DA; Doherty E; O'Donnell M; Seed M; Brown EA
    Adv Perit Dial; 1997; 13():168-73. PubMed ID: 9360675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein metabolism in renal replacement therapy: a review.
    Kronenberg F; Dieplinger H; König P; Utermann G
    Isr J Med Sci; 1996 Jun; 32(6):371-89. PubMed ID: 8682643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol and lipid disturbances in renal disease: the natural history of uremic dyslipidemia and the impact of hemodialysis and continuous ambulatory peritoneal dialysis.
    Avram MM; Fein PA; Antignani A; Mittman N; Mushnick RA; Lustig AR; Lapuz MH; Goldwasser P
    Am J Med; 1989 Nov; 87(5N):55N-60N. PubMed ID: 2486549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lipoprotein (a) is a risk factor for cerebrovascular accident in patients with chronic renal failure].
    Ishikawa H
    Nihon Jinzo Gakkai Shi; 1994 Jul; 36(7):846-52. PubMed ID: 8072223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.